We are constantly exposed to chemicals and other agents in our environment that can influence our risk of tumorigenesis, but exactly how these factors contribute to cancer development is largely unknown. Fine particulate matter measuring ≤2.5 μm (PM2.5) from air pollution can accumulate in alveoli, contributing to inflammation and tissue damage. Despite prior correlative studies highlighting the mortality risk, there has been a historical reluctance to lower national standards for safe PM2.5 exposure. A recent publication further highlights the attributable risk of PM2.5 exposure with lung cancer – particularly in ‘never-smokers’ with EGFR-driven non-small cell lung cancer. Importantly, it also elucidates a mechanistic link between PM2.5 exposure and tumorigenesis using in vivo models of EGFR non-small cell lung cancer. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
CITATION STYLE
Balasubramanian, A., John, T., & Adams, D. J. (2023, September 1). Breathing in danger: how particulate matter pollution is putting the public at risk of lung cancer†. Journal of Pathology. John Wiley and Sons Ltd. https://doi.org/10.1002/path.6160
Mendeley helps you to discover research relevant for your work.